StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Wednesday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.06 on Wednesday. The stock has a market capitalization of $5.75 million, a price-to-earnings ratio of -0.96 and a beta of […]
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Wednesday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NYSE:NAVB opened at $0.06 on Wednesday. The firm has a fifty day simple moving average of $0.06 and a two-hundred day simple […]
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published on Wednesday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NAVB opened at $0.06 on Wednesday. Navidea Biopharmaceuticals has a one year low of $0.02 and a one year high of […]
Analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research note issued on Wednesday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Up 8.9 % Shares of NYSE NAVB opened at $0.06 on Wednesday. The stock has a fifty day moving average price […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Monday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE:NAVB opened at $0.05 on Monday. The firm’s fifty day moving average is $0.06 and its 200-day moving average is $0.07. Navidea Biopharmaceuticals […]